Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome

Mason, 2004, Aspirin resistance: current concepts, Rev Cardiovasc Med, 5, 156 Mason, 2005, Aspirin resistance and atherothrombotic disease, J Am Coll Cardiol, 46, 986, 10.1016/j.jacc.2004.08.070 Lev, 2006, Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance, J Am Coll Cardiol, 47, 27, 10.1016/j.jacc.2005.08.058 Gurbel, 2003, Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity, Circulation, 107, 2908, 10.1161/01.CIR.0000072771.11429.83 Siller-Matula, 2007, Thienopyridines in cardiovascular disease: focus on clopidogrel resistance, Thromb Haemost, 97, 385, 10.1160/TH06-08-0420 Barragan, 2003, Resistance to thienopyridines: clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation, Catheter Cardiovasc Interv, 59, 295, 10.1002/ccd.10497 Cuisset, 2006, High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome, J Thromb Haemost, 4, 542, 10.1111/j.1538-7836.2005.01751.x Chen, 2007, Aspirin resistance and adverse clinical events in patients with coronary artery disease, Am J Med, 120, 631, 10.1016/j.amjmed.2006.10.021 Chen, 2004, Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment, J Am Coll Cardiol, 43, 1122, 10.1016/j.jacc.2003.12.034 Matetzky, 2004, Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction, Circulation, 109, 3171, 10.1161/01.CIR.0000130846.46168.03 Price, 2008, Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation, Eur Heart J, 10.1093/eurheartj/ehn046 Cuisset, 2006, Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non–ST-segment elevation acute coronary syndrome undergoing coronary stenting, J Am Coll Cardiol, 48, 1339, 10.1016/j.jacc.2006.06.049 Montalescot, 2006, J Am Coll Cardiol, 48, 931, 10.1016/j.jacc.2006.04.090 Patti, 2005, Circulation, 111, 2099, 10.1161/01.CIR.0000161383.06692.D4 von Beckerath, 2007, A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days, Eur Heart J, 28, 1814, 10.1093/eurheartj/ehl489 Wolfram, 2006, Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention, Am J Cardiol, 97, 984, 10.1016/j.amjcard.2005.10.064 Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138 Thygesen, 2007, Universal definition of myocardial infarction, Circulation, 116, 2634, 10.1161/CIRCULATIONAHA.107.187397 Cutlip, 2007, Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313 Ong, 2005, Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation, J Am Coll Cardiol, 45, 947, 10.1016/j.jacc.2004.09.079 Daemen, 2007, Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study, Lancet, 369, 667, 10.1016/S0140-6736(07)60314-6 Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126 Albiero, 1997, Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Comparison of aspirin alone versus combined ticlopidine and aspirin therapy, Circulation, 95, 1145, 10.1161/01.CIR.95.5.1145 Bertrand, 1998, Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study, Circulation, 98, 1597, 10.1161/01.CIR.98.16.1597 Cadroy, 2000, Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans, Circulation, 101, 2823, 10.1161/01.CIR.101.24.2823 Eisenstein, 2007, Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation, JAMA, 297, 159, 10.1001/jama.297.2.joc60179 Jeong, 1996, Porcine model of stent thrombosis: platelets are the primary component of acute stent closure, Cathet Cardiovasc Diagn, 38, 38, 10.1002/(SICI)1097-0304(199605)38:1<38::AID-CCD9>3.0.CO;2-4 Bonello, 2008, Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study, J Am Coll Cardiol, 51, 1404, 10.1016/j.jacc.2007.12.044 Lee, 2006, Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials), Am J Cardiol, 98, 718, 10.1016/j.amjcard.2006.03.059 Mukherjee, 2005, Variation in outcomes after percutaneous coronary intervention in the United States and predictors of periprocedural mortality, Cardiology, 103, 143, 10.1159/000084029 Osten, 2008, Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention, Am J Cardiol, 101, 780, 10.1016/j.amjcard.2007.11.009 Valgimigli, 2007, Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial, J Am Coll Cardiol, 49, 431, 10.1016/j.jacc.2006.06.081 Cheneau, 2003, Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study, Circulation, 108, 43, 10.1161/01.CIR.0000078636.71728.40 de la Torre-Hernandez, 2008, Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos), J Am Coll Cardiol, 51, 986, 10.1016/j.jacc.2007.10.057 Katayama, 2006, Predictors of sub-acute stent thrombosis in acute myocardial infarction patients following primary coronary stenting with bare metal stent, Circ J, 70, 151, 10.1253/circj.70.151